Skip to main content
Clinical Trials/CTRI/2019/04/018778
CTRI/2019/04/018778
Completed
Phase 4

A Randomized Controlled Clinical Study on the efficacy of Guda-Haritaki in Kaphaja Pratishaya with special reference to Allergic Rhinitis in children

Dattatray Chavan0 sites197 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: J310- Chronic rhinitis
Sponsor
Dattatray Chavan
Enrollment
197
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 21, 2022
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dattatray Chavan

Eligibility Criteria

Inclusion Criteria

  • Children are with symptoms of Kaphaja Pratishaya (Allergic Rhinitis) of age 6 to 12 years1\.
  • Patients will be selected irrespective of sex and religion.
  • Patients, whose parents are willing to participate their child in the study and
  • are ready to sign informed consent form will be selected for the study.
  • Children with symptoms of Allergic Rhinitis occur for \> 4 days per week and / or for \> 4 consecutive weeks at a time.
  • The laboratory finding of increased numbers of eosinophils in the nasal mucosal smear (presence of \> 4 % eosinophils for 6 to 10 years of age and \>10 % eosinophils for 11 to 12 years of age) and elevated Total Serum IgE concentration ( \> 20 IU/ml)that patients will be selected.

Exclusion Criteria

  • Patients with nasal abnormalities like D.N.S., Nasal polyps, adenoid and tonsilar hypertrophy.
  • Patients with acute respiratory infection or severe concomitant disease (Tuberculosis, Pneumonia).
  • Malnourished child.

Outcomes

Primary Outcomes

Not specified

Similar Trials